SEC Tracker
Get the app

TRex Bio TRXB

TRex Bio (LLY) purchased 875,000 shares in IPO for $12.3M

Ownership stake disclosure by ELI LILLY & Co

Form
Schedule 13D
Filed
Importance
Notable
  1. Eli Lilly owns 5,480,872 shares of TRex Bio
  2. Shares include 2,510,411 from Series A conversion
  3. Includes 2,095,461 from Series B conversion
  4. Purchased 875,000 shares in IPO for $12.3M

Written from the Schedule 13D on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when TRex Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX